Companies / BOC Sciences / Abagovomab
BOC Sciences

Abagovomab | BOC Sciences

Abagovomab is a murine IgG1 monoclonal anti-idiotype antibody that functionally imitates the tumor-associated antigen, CA-125. Abagovomab has been used in the research of ovarian cancer treatment.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.